Inflammation Clinical Trial
Official title:
Evaluation of the Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation on Healthy Non-resistance Trained Participants
This is a randomized, repeated measures and double blind study which measures the effect of fenugreek extract on markers of muscle damage and inflammation in non-resistance trained males. Participants will complete baseline testing and then be randomized into groups. Participants will complete a 2 week, split-body resistance training program. They will then return for testing in which they will complete an overreaching protocol for 5 consecutive days. Measurements will be recorded 24 hrs after the fifth day. Participants will resume the training program for one additional week and return for final measurements.
Subjects expressing interest in doing the study will be interviewed in the UMHB Human
Performance Lab (HPL) to determine whether they qualify to participate in the study. Upon
qualification, participants will be scheduled a familiarization session in which they will be
taught how to perform a proper bench press, back squat, deadlift and squat thruster. They
will then schedule their first testing session which will include: a body composition
analysis via an InBody 770, thigh circumference measurements, joint mobility measurements, a
blood draw, strength testing (1RM), and muscular endurance testing (70% 1RM max reps).
Participants will then be placed in groups based on fat free mass and assigned their workout
program (3days/week) with training loads based on their 1RM values (bench press, back squat,
deadlift and squat thruster).
Supplementation protocol: Participants will be randomly assigned into one of three groups and
instructed to ingest capsules of either a placebo, or IND03 (fenugreek extract) containing
300mg, or 500mg. They will supplement 1 hour prior to their workout each exercise day as well
as during the overreaching week. On "off/rest" days, participants will consume capsules in
the morning with breakfast.
After two weeks of training, participants will return to the HPL for follow-up strength
testing (1RM), and muscular endurance testing (70% 1RM max reps), then instructed to rest for
48 hours and return to the lab to begin their overreaching protocol. During each of the 5
days, participants undergo the following measurements prior to the exercise protocol: thigh
circumference, joint mobility, and questionnaires (WOMAC & VAS). On Day 1 participants will
also perform an InBody and blood draw. A blood draw will also be performed on Day 3. They
will then consume a standardized snack and begin the overreaching protocol of 8 sets of 10
repetitions for the following 4 exercises: bench press, back squat, deadlift and squat
thruster. There will be a 1 minute rest period in between each set and a 2 minute rest in
between each exercise. Participants will then fill out a Rate of Perceived Exertion (RPE)
immediately after the protocol. Again, they will perform this for 5 consecutive days.
Twenty-four hours after the last overreaching day, participants will return for thigh
circumference, joint mobility, questionnaires (WOMAC & VAS), a blood draw, strength testing
(1RM), and muscular endurance testing (70% 1RM max reps). They will then be instructed to
continue the resistance training program for 1 week. After that period they will return for
final measurements of thigh circumference, joint mobility, questionnaires (WOMAC & VAS), a
blood draw, strength testing (1RM), and muscular endurance testing (70% 1RM max reps).
Throughout the duration of the study, participants will record their dietary intake via
MyFitnessPal.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06422494 -
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
|
N/A | |
Not yet recruiting |
NCT05910489 -
Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
|